









Markets
/
Stocks
/
nasdaq-oprx
/

OptimizeRx Corp

OPRX

6.460USD

-0.500-7.18%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

30.56MMarket Cap

23.36P/E TTM



OptimizeRx Corp

6.460

-0.500-7.18%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of OptimizeRx Corp

Currency: USD Updated: 2026-03-27

Key Insights

OptimizeRx Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 54 out of 480 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.50.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

OptimizeRx Corp's Score

Industry at a Glance

Industry Ranking

54 / 480

Overall Ranking

126 / 4542

Industry

Software & IT Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

OptimizeRx Corp Highlights

StrengthsRisks

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 53.00% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Overvalued

The company’s latest PE is 23.86, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 14.19M shares, decreasing 30.07% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 1.73K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.89.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

14.500

Target Price

+108.33%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of OptimizeRx Corp is 8.51, ranking 52 out of 480 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 32.24M, representing a year-over-year decrease of 0.24%, while its net profit experienced a year-over-year decrease of 6535.90%.

Score

Industry at a Glance

Previous score

8.51

Change



Financials

9.04

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.28

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.07

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.63

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.53

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

OptimizeRx Corp's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of OptimizeRx Corp is 7.11, ranking 313 out of 480 in the Software & IT Services industry. Its current P/E ratio is 23.86, which is 15915.49% below the recent high of 3821.76 and 269.34% above the recent low of -40.41.

Score

Industry at a Glance

Previous score

7.11

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 54/480

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of OptimizeRx Corp is 8.29, ranking 75 out of 480 in the Software & IT Services industry. The average price target is 24.00, with a high of 32.00 and a low of 17.00.

Score

Industry at a Glance

Previous score

8.29

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

14.500

Target Price

+119.70%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

113

Total

Median

Average

Company name

Ratings

Analysts

OptimizeRx Corp

OPRX

Meta Platforms Inc

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of OptimizeRx Corp is 7.29, ranking 53 out of 480 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 7.87 and the support level at 5.43, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.86

Change

-1.57

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.348

Neutral

RSI(14)

40.201

Neutral

STOCH(KDJ)(9,3,3)

45.185

Sell

ATR(14)

0.473

High Vlolatility

CCI(14)

1.410

Neutral

Williams %R

64.950

Sell

TRIX(12,20)

-1.099

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

6.796

Sell

MA10

6.548

Sell

MA20

6.694

Sell

MA50

8.576

Sell

MA100

11.398

Sell

MA200

13.913

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of OptimizeRx Corp is 7.00, ranking 142 out of 480 in the Software & IT Services industry. The latest institutional shareholding proportion is 76.12%, representing a quarter-over-quarter increase of 4.70%. The largest institutional shareholder is The Vanguard, holding a total of 1.14M shares, representing 6.06% of shares outstanding, with 21.58% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Whetstone Capital Advisors, LLC

1.51M

Weintraub (Michael)

1.38M

The Vanguard Group, Inc.

Star Investors

1.06M

+15.01%

BlackRock Institutional Trust Company, N.A.

1.06M

-3.35%

Royce Investment Partners

Star Investors

677.33K

-14.33%

Kennedy Capital Management LLC

674.92K

+42.85%

Rice Hall James & Associates, LLC

545.82K

-10.16%

William Blair & Company, L.L.C. (Research)

591.14K

-6.01%

Parkman Healthcare Partners LLC

509.61K

+0.43%

Febbo (William J)

530.85K

-13.54%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of OptimizeRx Corp is 4.19, ranking 267 out of 480 in the Software & IT Services industry. The company's beta value is 1.24. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.